- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01561872
Assessment of an Automated Telesurveillance System on Serious Falls Prevention in an Elderly Suffering From Dementia Specialized Care Unit: the URCC (GET-BETTER)
February 12, 2015 updated by: University Hospital, Limoges
Assessment of an Automated Telesurveillance System on Serious Falls Prevention in an Elderly Suffering From Dementia Specialized Care Unit: the URCC. GET-BETTER Study (Geriatric Environmental Telecare - Behavioral Engineering Technology To Enhance Rehabilitation)
2 URCC in the Limousin region will be equipped with the automated telesurveillance system.
Patient will be selected by ward's geriatrician and randomized into two groups after informed consent.
One group will have cameras installed and the other will not and will act as a comparison group.
Patient will be assessed twice during the study, at admission in (inclusion visit) and at outcome from the URCC (end of study visit).
Each assessment implies a standard geriatric assessment, a fall questionnaire, a Neuropsychiatric inventory for behavioral disturbances and a quality of life questionnaire (EQ5D).
Every fall will be considered as adverse events and will therefore be listed along the study and characterized in types and number.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
350
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Limoges, France, 87042
- Limoges university hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
demented old subjects
Description
Inclusion Criteria:
- Patient aged more than 65 years old
- Patient admitted in Limoges or Brive's URCC
- Patient informed consent and/or proxy consent
- Patient covered by the French health insurance
Exclusion Criteria:
- Patient without national health insurance coverage
- Patient with a short term prognosis pathology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
intervention group
Rooms of the patient of the "intervention group" will be equipped of cameras
|
reference group
Patient in the "non-equipped" group will have usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The impact of the automated telesurveillance system
Time Frame: 6 months
|
The impact of the automated telesurveillance system on the incidence rate of falls with serious outcomes between the two groups during their hospitalization in URCC.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The impact of the system on the global rate of falls
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (ACTUAL)
November 1, 2014
Study Completion (ACTUAL)
February 1, 2015
Study Registration Dates
First Submitted
March 21, 2012
First Submitted That Met QC Criteria
March 21, 2012
First Posted (ESTIMATE)
March 23, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
February 13, 2015
Last Update Submitted That Met QC Criteria
February 12, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I11 005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mentally Ill Old Subjects
-
VA Office of Research and DevelopmentCompletedVeterans | Homeless Persons | Mentally Ill PersonsUnited States
-
Lev-Hasharon Mental Healtlh CenterUnknown
-
Johns Hopkins UniversityCompletedAlcoholism | Substance-related Disorders | Mentally Ill Chemical Abuse | Educational Technology
-
Washington University School of MedicineCompletedObesity | Mentally Ill PersonsUnited States
-
NestléCompletedCritically Ill Mechanically Ventilated SubjectsUnited States, Canada
-
Children's Hospital Medical Center, CincinnatiNational Institutes of Health (NIH)CompletedMental Disorders | Emergency Medicine | Mentally Ill PersonsUnited States
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)CompletedHIV Infections | Substance Abuse | Mentally Ill PersonsUnited States
-
Bavarian NordicUS Army Medical Research Institute of Infectious DiseasesCompleted18-42 Year Old Healthy Vaccinia-naïve SubjectsKorea, Republic of
-
Galderma R&DCompletedHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected SkinFrance